// App-Quantinova.ai

191 : Testosterone levels in metastatic castration-resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Christoph A. J. von Klot

Principal Investigators

  • Alena Boeker

  • Axel S. Merseburger

  • Thomas R. W. HerrmAnn Mario W. Kramer

  • Markus A. Kuczyk

Medical Centers

  • Dept. Urology and Urologic Oncology, Medical School Hannover, Hannover, Germany

  • Hannover Medical School, Hannover, GermanyDepartment of Urology and Urologic Oncology, Hannover Medical School, Hannover, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Testosterone

Drug/Treatment

  • CB-7598

  • Enzalutamide

  • Cabazitaxel

  • Carboplatin

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved